巴西心血管器械市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

巴西心血管设备市场按设备类型(诊断和监测设备以及治疗和手术设备)进行细分。

市场快照

brazil cardiovascular devices market analysis
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 2.5 %
brazil cardiovascular devices market major players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

巴西心血管器械市场预计在预测期内的复合年增长率为 2.5%。推动巴西市场增长的主要因素是心血管疾病负担的增加和微创手术的采用增加。

根据 Gagnon-Arpin 等人 2017 年的研究报告,预计到 2035 年,巴西成年人的心血管疾病 (CVD) 患病率将增加到 1360 万,而包括直接和间接成本在内的经济负担将增加到400 亿美元。

此外,由于巴西对各种心脏病的认识不断提高,以及该国老年人口数量的增加,预计在预测期内将出现显着增长。

Scope of the report

As per the scope of the report, Cardiovascular diseases are a group of disorders of the heart and blood vessels that includes coronary heart disease, peripheral arterial disease, congenital heart disease, and cerebrovascular disease. The cardiovascular devices are used to treat or prevent different cardiovascular conditions. The Brazil Cardiovascular Devices Market is segmented by device type.

By Device Type
Diagnostic and Monitoring Devices
Electrocardiogram (ECG)
Remote Cardiac Monitoring
Other Diagnostic and Monitoring Devices
Therapeutic and Surgical Devices
Cardiac Assist Devices
Cardiac Rhythm Management Device
Catheter
Grafts
Heart Valves
Stents
Other Therapeutic and Surgical Devices

Report scope can be customized per your requirements. Click here.

主要市场趋势

心电图 (ECG) 预计将在预测期内主导诊断和监测部分

心电图 (ECG) 记录来自心脏的电信号。这是一种常见且无痛的测试,用于检测心脏问题和监测心脏健康。

根据世界卫生组织 (WHO) 2017 年的数据,2017 年巴西约有 164,557 人或总死亡人数的 15.56% 死于冠心病,被认为是最高的死因。随着心血管设备的有效采用,这可以略微减少。

目前,便携式和紧凑型心电图 (ECG) 正在推动其更大范围的采用,尤其是在家庭医疗保健领域。此外,通过采用这些设备增加该国的心血管疾病有助于监测心脏状况。因此,由于上述因素,预计该细分市场在不久的将来将显示出健康的增长率。

brazil cardiovascular devices market trends

brazil cardiovascular devices market size

竞争格局

巴西心血管设备市场竞争激烈。主要参与者已经在特定的市场领域确立了自己的地位。目前主导市场的一些参与者是 Medtronic, Inc (Covidien Plc)、波士顿科学公司、Edwards Lifesciences、雅培实验室、Cardinal Health Inc、CR Bard, Inc、Terumo Corporation、Braile Biomedica Ltda 和 Biotronik SE & Co。公斤。

主要玩家

  1. Medtronic, Inc (Covidien Plc)

  2. Boston Scientific Corporation

  3. Abbott Laboratories

  4. Cardinal Health Inc

  5. Edwards Lifesciences

Medtronic, Inc (Covidien Plc) Boston Scientific Corporation Abbott Laboratories Cardinal Health Inc Edwards Lifesciences

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Burden of Cardiovascular Diseases

      2. 4.2.2 Increased Preference of Minimally Invasive Procedures

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Policies

      2. 4.3.2 High Cost of Instruments and Procedures

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Device Type

      1. 5.1.1 Diagnostic and Monitoring Devices

        1. 5.1.1.1 Electrocardiogram (ECG)

        2. 5.1.1.2 Remote Cardiac Monitoring

        3. 5.1.1.3 Other Diagnostic and Monitoring Devices

      2. 5.1.2 Therapeutic and Surgical Devices

        1. 5.1.2.1 Cardiac Assist Devices

        2. 5.1.2.2 Cardiac Rhythm Management Device

        3. 5.1.2.3 Catheter

        4. 5.1.2.4 Grafts

        5. 5.1.2.5 Heart Valves

        6. 5.1.2.6 Stents

        7. 5.1.2.7 Other Therapeutic and Surgical Devices

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Medtronic, Inc (Covidien Plc)

      2. 6.1.2 Boston Scientific Corporation

      3. 6.1.3 Edwards Lifesciences

      4. 6.1.4 Abbott Laboratories

      5. 6.1.5 Cardinal Health Inc

      6. 6.1.6 C.R. Bard, Inc

      7. 6.1.7 Terumo Corporation

      8. 6.1.8 Braile Biomedica Ltda

      9. 6.1.9 Biotronik SE & Co. KG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Brazil Cardiovascular Devices Market market is studied from 2018 - 2026.

The Brazil Cardiovascular Devices Market is growing at a CAGR of 2.5% over the next 5 years.

Medtronic, Inc (Covidien Plc), Boston Scientific Corporation, Abbott Laboratories, Cardinal Health Inc, Edwards Lifesciences are the major companies operating in Brazil Cardiovascular Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!